Analysts have been eager to weigh in on the Healthcare sector with new ratings on Medpace Holdings (MEDP – Research Report) and Silk Road Medical (SILK – Research Report).
Medpace Holdings (MEDP)
Medpace Holdings received a Buy rating and a $289.00 price target from Robert W. Baird analyst Eric Coldwell today. The company’s shares closed last Monday at $227.52.
According to TipRanks.com, Coldwell is a 4-star analyst with an average return of
Currently, the analyst consensus on Medpace Holdings is a Moderate Buy with an average price target of $279.50.
See the top stocks recommended by analysts >>
Silk Road Medical (SILK)
Wolfe Research analyst Michael Polark upgraded Silk Road Medical to Hold yesterday. The company’s shares closed last Monday at $6.30.
According to TipRanks.com, Polark is a 4-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Silk Road Medical with a $15.29 average price target, a 128.2% upside from current levels. In a report issued on October 10, Stifel Nicolaus also downgraded the stock to Hold with a $12.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on MEDP:
